The same study identified retinoic acid receptors (RARs) as nuclear receptors that regulate gene expression in response to retinoic acid, a metabolite of vitamin A. RAR activation has demonstrated anti-tumor effects in various tumor models. The gene discussed is RARS1; the disease is neoplasm.